Search research articles
Contact Us
Filters
Showing results (651-660 of 688) with videos related to
Page
of 69
Sort By:
Thescientificworldjournal
|
December 19, 2013
A multigene approach for comparing genealogy of Betacoronavirus from cattle and horses
Iracema N Barros, Sheila O S Silva, Francisco S Nogueira Neto, et al.
Journal of Diabetes and Its Complications
|
September 1, 1996
Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus
Y Okuda, M Mizutani, M Ogawa, et al.
Journal of Medicinal Chemistry
|
October 10, 1998
A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a] pyridine moiety
Y Abe, H Kayakiri, S Satoh, et al.
Journal of Medicinal Chemistry
|
November 7, 1998
A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation
Y Abe, H Kayakiri, S Satoh, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
August 15, 2002
[Endobronchial brachytherapy for intra-luminal recurrence after lung cancer resection]
D Kataoka, M Kadokura, M Nonaka, et al.
Atherosclerosis
|
July 25, 1998
Influence of cellular incorporation of n-3 eicosapentaenoic acid on intracellular Ca2+ concentration and membrane potential in vascular smooth muscle cells
M Asano, T Nakajima, H Hazama, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 20, 2000
Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells
K Hayashi, W Natsume, T Watanabe, et al.
Molecular and Cellular Biology
|
April 21, 2001
Six4, a putative myogenin gene regulator, is not essential for mouse embryonal development
H Ozaki, Y Watanabe, K Takahashi, et al.
Journal of Medicinal Chemistry
|
March 4, 1998
A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework
Y Abe, H Kayakiri, S Satoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 24, 1999
[Arterial infusion therapy with implantable port for inoperable hepatobiliary tumors]
S Higashi, C Kato, H Sakumoto, et al.
Page
of 69
Search research articles
Search
Showing results (651-660 of 688) with videos related to
Sort By:
Page
of 69
Thescientificworldjournal
|
December 19, 2013
A multigene approach for comparing genealogy of Betacoronavirus from cattle and horses
Iracema N Barros, Sheila O S Silva, Francisco S Nogueira Neto, et al.
Journal of Diabetes and Its Complications
|
September 1, 1996
Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus
Y Okuda, M Mizutani, M Ogawa, et al.
Journal of Medicinal Chemistry
|
October 10, 1998
A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a] pyridine moiety
Y Abe, H Kayakiri, S Satoh, et al.
Journal of Medicinal Chemistry
|
November 7, 1998
A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation
Y Abe, H Kayakiri, S Satoh, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
August 15, 2002
[Endobronchial brachytherapy for intra-luminal recurrence after lung cancer resection]
D Kataoka, M Kadokura, M Nonaka, et al.
Atherosclerosis
|
July 25, 1998
Influence of cellular incorporation of n-3 eicosapentaenoic acid on intracellular Ca2+ concentration and membrane potential in vascular smooth muscle cells
M Asano, T Nakajima, H Hazama, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 20, 2000
Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells
K Hayashi, W Natsume, T Watanabe, et al.
Molecular and Cellular Biology
|
April 21, 2001
Six4, a putative myogenin gene regulator, is not essential for mouse embryonal development
H Ozaki, Y Watanabe, K Takahashi, et al.
Journal of Medicinal Chemistry
|
March 4, 1998
A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework
Y Abe, H Kayakiri, S Satoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 24, 1999
[Arterial infusion therapy with implantable port for inoperable hepatobiliary tumors]
S Higashi, C Kato, H Sakumoto, et al.
Page
of 69